Cargando…
c-MYC inhibition impairs hypoxia response in glioblastoma multiforme
The c-MYC oncoprotein is a DNA binding transcription factor that enhances the expression of many active genes. c-MYC transcriptional signatures vary according to the transcriptional program defined in each cell type during differentiation. Little is known on the involvement of c-MYC in regulation of...
Autores principales: | Mongiardi, Maria Patrizia, Savino, Mauro, Falchetti, Maria Laura, Illi, Barbara, Bozzo, Francesca, Valle, Cristiana, Helmer-Citterich, Manuela, Ferrè, Fabrizio, Nasi, Sergio, Levi, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078092/ https://www.ncbi.nlm.nih.gov/pubmed/27119353 http://dx.doi.org/10.18632/oncotarget.8921 |
Ejemplares similares
-
Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells
por: Mongiardi, Maria Patrizia, et al.
Publicado: (2015) -
The “Superoncogene” Myc at the Crossroad between Metabolism and Gene Expression in Glioblastoma Multiforme
por: Cencioni, Chiara, et al.
Publicado: (2023) -
Glioblastoma Cells Do Not Affect Axitinib-Dependent Senescence of HUVECs in a Transwell Coculture Model
por: Merolle, Matilde, et al.
Publicado: (2020) -
Cancer Response to Therapy-Induced Senescence: A Matter of Dose and Timing
por: Mongiardi, Maria Patrizia, et al.
Publicado: (2021) -
Myc beyond Cancer: Regulation of Mammalian Tissue Regeneration
por: Illi, Barbara, et al.
Publicado: (2023)